|
Co-Chairs:
Annie Chicoye PhD , Senior Principal Director Pricing & Market Access, IMS HEALTH, Puteaux-Cedex, France
Geoffrey Wilson MSc, BSc, DPhil, Reimbursement Leader, Europe, Middle East, Africa Region, GE Healthcare, UK
Leadership Group:
THERAPEUTICS DEVICES
Team leaders:
- Annie Chicoye PhD, Senior Principal Director Pricing & Market Access, IMS HEALTH, Puteaux-Cedex, France
- Gregory De Lissovoy PhD, MPH, Vice President, United BioSource Corporation, Bethesda, MD, USA
- Kathleen A. Foley, PhD, Jefferson School of Population Health, Health Economics and Outcomes Research, Thomas Jefferson University
- Nancy Nickman PhD, Professor of Pharmacotherapy, University of Utah, Salt Lake City, UT, USA
- Frederic Rupprecht MBA, MSc, Global Director, HTA & EBM, Ethicon Endo-Surgery, Mission Viejo, CA, USA
- Feng Xie PhD, MSc, BSc, Assistant Professor, PATH Research Institute, McMaster University, Hamilton, ON, Canada
Team members
- Nelson Alvis PhD, MD, MPH, PROFESOR – INVESTIGADOR, UNIVERSIDAD DE CARTAGENA, Cartagena, Colombia
- Sophie Cros PharmD, MBA, Director, Reimbursement and Health Economics, Abbott Vascular International BVBA, Diegem, Belgium
- Robert Launois PhD, Professor, REES France, Paris, France
- Anuprita Patkar PhD, Associate Director, Ethicon, Princeton, USA
- Marianne Van Genugten, Reimbursement manager, Medtronic Trading NL BV, Vianen, Netherlands
- Zhexiang Zhao PhD, Research Scientist, Eli Lilly and Company, Indianapolis, IN, USA
- Franck Maunoury MSc, Director, Consultant, Statésia, Le Mans, France
DIAGNOSTICS DEVICES
Team Leaders
- Vasily Belozeroff PhD, Health Economics, Amgen, Inc, Thousand Oaks, CA, USA
- Susan Garfield MSc, BA, Vice President, Bridgehead International, Wayland, MA, USA
- Anke-Peggy Holtorf PhD, MBA, Business Director Europe, BioBridge Strategies, Basel, Switzerland
- Darron Segall MS, MHA, Manager, Reimbursement & Health Economics, Quidel Corporation, San Diego, CA, USA
- Lizheng Shi PhD, MS, Assistant Professor, Tulane University SPHTM, New Orleans, LA, USA
- Stylianos Tsintzos MD, MSc, SQDM Health Economics and Reimbursement Analyst, Medtronic International Trading, Tolochenaz, Switzerland
- Geoffrey Wilson MSc, BSc, DPhil, Reimbursement Leader, Europe, Middle East, Africa Region, GE Healthcare, Buckinghamshire, UK
Team members
- Stephanie Earnshaw PhD, Vice President, Health Economics US, RTI Health Solutions, Research Triangle Park, NC, USA
- Eric Faulkner, RTI Health Solutions, Research Triangle Park, NC, USA
- Steven Kymes PhD, MHA, Research Assistant Professor, Washington University School of Medicine, Saint Louis, MO, USA
- Tracy Li PhD, Director, Immunology, Bristol-Myers Squibb Co., Princeton, NJ, USA
- Gilbert L'italien PhD, Epidemiologist, Bristol-Myers Squibb, Wallingford, CT, USA
- Ken Redekop PhD, MPH, Senior researcher, Erasmus MC (iMTA), Rotterdam, Netherlands
- Stanley Skrzypczak MS, MBA, Assoc. Director, Managed Care Marketing, Genomic Health, Inc, Redwood City, CA, USA
Overview:
As compared to pharmaceutical technology, medical device & diagnostics technology has unique features in terms of conception, development, introduction into medical practice, and utilization over time. These features influence the type and level of evidence needed to support regulatory approval as well reimbursement by health care systems. The HTA for Medical Device & Diagnostics Working Group will address, and hopefully bring clarity, to the unique features of medical device & diagnostic technology outcomes research as well as use of this research in coverage and reimbursement decisions.
Goal:
The goal of the HTA for Medical Devices and Diagnostics Working Group is to develop information on the health care reimbursement system and decision-making processes for medical devices and diagnostics around the world and to identify topics for development of good research practices in the conduct of medical devices and diagnostics outcomes research.
Objectives:
- Describe the health care decision making processes, HTA review and Reimbursement systems for medical devices and diagnostics globally for inclusion in the Global Health Care Systems Roadmap at: http://www.ispor.org/HTARoadMaps/Default.asp
- Promote discussion with decisions makers on topics on which good research practices can be developed
|
